OMC
59
4
VLO
33
4
AES
43
5
PRGO
39
-4
VFC
65
2
LEN
52
4
HBI
50
-2
AEP
43
3
APD
47
-2
CMCSA
59
6
BF.B
31
2
ADP
65
4
EMC
62
6
MRK
25
2
FSLR
63
6
NWL
54
-2
UNP
42
-4
DGX
33
-6
BSX
61
2
HRB
54
2
OMC
59
4
VLO
33
4
AES
43
5
PRGO
39
-4
VFC
65
2
LEN
52
4
HBI
50
-2
AEP
43
3
APD
47
-2
CMCSA
59
6
BF.B
31
2
ADP
65
4
EMC
62
6
MRK
25
2
FSLR
63
6
NWL
54
-2
UNP
42
-4
DGX
33
-6
BSX
61
2
HRB
54
2
Financhill
Back

Lifecore Biomedical Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
39

LFCR
Lifecore Biomedical

Last Price:
5.99
Seasonality Move:
1.22%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Lifecore Biomedical Price Quote

$5.99
+0.01 (+1.96%)
(Updated: November 5, 2024 at 5:32 AM ET)

Lifecore Biomedical Key Stats

Sell
39
Lifecore Biomedical (LFCR) is a Sell
Day range:
$5.80 - $6.08
52-week range:
$3.68 - $8.90
Dividend yield:
0%
P/E ratio:
18.69
P/S ratio:
1.64
P/B ratio:
0%
Volume:
84.3K
Avg. volume:
126.8K
1-year change:
-17.29%
Market cap:
$220.2M
Revenue:
$128.3M
EPS:
$0.05

How Much Does Lifecore Biomedical Make?

Is Lifecore Biomedical Growing As A Company?

  • What Is Lifecore Biomedical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.01%
  • What Is Lifecore Biomedical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Lifecore Biomedical Stock Price Performance

What Is Lifecore Biomedical 52-Week High & Low?

Lifecore Biomedical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Lifecore Biomedical?

Is Lifecore Biomedical Cash Flow Positive?

  • What Is LFCR Cash Flow From Operations?
    Cash flow from operations (TTM) is $7.5M
  • What Is Lifecore Biomedical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $5.7M
  • What Is Lifecore Biomedical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$16.3M

Lifecore Biomedical Return On Invested Capital

  • Is Management Doing A Good Job?
    LFCR return on invested capital is 5.48%
  • What Is Lifecore Biomedical Return On Assets?
    ROA measures how assets are converting to revenues and is 2.64%
  • What Is LFCR Return On Equity?
    ROE is a measure of profitability and is 252.9%

Lifecore Biomedical Earnings Date & Stock Price

Lifecore Biomedical Competitors

  • Who Are Lifecore Biomedical's Competitors?
    Below is a list of companies who compete with Lifecore Biomedical or are related in some way:
    • AngioDynamics Inc (ANGO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Outset Medical Inc (OM)
    • Precision Optics Corp Inc (POCI)
    • Sage Therapeutics Inc (SAGE)

Lifecore Biomedical Dividend Yield

Lifecore Biomedical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 19.51%
Revenue: 0.75% 6.54%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 7.00
Upside from Last Price: 17.06%

Major Shareholders

  • How many LFCR shares are owned by institutional investors?
    29.4M LFCR shares are owned by institutional investors
  • How many LFCR shares are owned by insiders?
    3.4M LFCR shares are owned by insiders